The Chinese technology giant Tencent has developed an artificial intelligence (AI) programme that can speed up the process of diagnosing Parkinson’s disease.
Developed in collaboration with the London-based medical firm Medopad, the AI uses cameras that monitor how patients move their hands in order to evaluate the severity of their symptoms.
The AI has been trained to identify symptoms by studying existing video footage of Parkinson’s patients, says Forbes. The process, often referred to as machine learning, was completed with the help of London’s King’s College Hospital.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The process of monitoring a patient’s symptoms normally takes about half an hour, but the tech developed through the partnership could cut that down to three minutes.
According to Wei Fan, Tencent’s head of medical research, the technology would allow medical professionals to set drug dosage levels and monitor patients without the need for hospital visits, Bloomberg reports.
In an interview with the BBC, Medopad’s chief executive Dan Vahdat said the company had been hoping to create an AI programme for smartphones that was capable of detecting Parkinson’s symptoms but couldn’t find a Britain-based firm that could match “what Tencent offered as a partner.”
“Our ambition is to impact a billion patients around the world – and to be able to get to that kind of scale we need to work with partners that have international reach”, he said.
Can these AI techniques be used for other diseases?
If the technology developed for Parkinson’s patients proves a reliable method for tracking symptoms it’s certainly a possibility.
The technology is still a prototype. But if the AI could be transferred onto a smartphone – an area that Medopad specialises in – it could be adapted for other diseases.
Fan and Vahdat told Bloomberg that the technology could be applied to childhood brain cancers, for example. It could also be used to monitor the progression of scoliosis (a spinal condition) in younger patients.
-
The most memorable podcasts of 2025The Week Recommends A round-up of the year's top podcasts that kept listeners tuned in
-
What is Roomba’s legacy after bankruptcy?In the Spotlight Tariffs and cheaper rivals have displaced the innovative robot company
-
SiriusXM hopes a new Howard Stern deal can turn its fortunes aroundThe Explainer The company has been steadily losing subscribers
-
AI griefbots create a computerized afterlifeUnder the Radar Some say the machines help people mourn; others are skeptical
-
The robot revolutionFeature Advances in tech and AI are producing android machine workers. What will that mean for humans?
-
Separating the real from the fake: tips for spotting AI slopThe Week Recommends Advanced AI may have made slop videos harder to spot, but experts say it’s still possible to detect them
-
Inside a Black community’s fight against Elon Musk’s supercomputerUnder the radar Pollution from Colossal looms over a small Southern town, potentially exacerbating health concerns
-
Poems can force AI to reveal how to make nuclear weaponsUnder The Radar ‘Adversarial poems’ are convincing AI models to go beyond safety limits
-
Spiralism is the new cult AI users are falling intoUnder the radar Technology is taking a turn
-
AI agents: When bots browse the webfeature Letting robots do the shopping
-
Is AI to blame for recent job cuts?Today’s Big Question Numerous companies have called out AI for being the reason for the culling
